Search for: "Hui Zhang"
Results 21 - 31
of 31
Sorted by Relevance
|
Sort by Date
15 Aug 2018, 12:48 am
Hui Zhang, Yi Wei and Jiao YuxinA Markush claim is a type of claim commonly used in chemical and pharmaceutical fields. [read post]
26 Aug 2014, 10:13 am
AutoChina International Limited, Hui Kai Yan, Rui Ge Dong, Victory First Limited, Rainbow Yield Limited, Yong Qi Li, Ai Xi Ji, Ye Wang, Zhong Wen Zhang, Li Xin Ma, Yong Li Li, and Shu Ling LiCase number: 12-cv-10643 (United States District Court for the District of Massachusetts)Case filed: April 11, 2012Qualifying Judgment/Order: June 25, 2014 [read post]
10 Feb 2017, 12:40 am
Hui Zhang, Jiao Yuxin and Dani MinZY PartnersA positive view is spreading on post-filing experimental data in China since the recent official post of the proposed revisions to the Guidelines for Patent Examination (the “Guidelines”) by the State IP Office (the “SIPO”) of China. [read post]
6 Jun 2017, 12:53 am
Hui Zhang, Xiang Li and Hanmei WangOn March 22, 2017, the Beijing IP Court (the “trial court”) issued a decision on a high-profile case Iwncomm v. [read post]
29 May 2018, 10:47 am
Hui Zhang, Mengling Liu and James Yang On March 28, 2018, the Beijing High Court issued its decision for Iwncomm v. [read post]
19 Feb 2019, 3:15 am
Hui Zhang, Yi Wei and Jiao YuxinThe Supreme People’s Court of China recently issued a new judicial interpretation regarding preliminary injunctions (PI) for intellectual property (IP) disputes that took effect on January 1, 2019, officially titled “Provisions of The Supreme People’s Court on Several Issues Concerning the Application of Laws in Adjudication of Action Preservation Cases Involving IP Disputes” (Provisions). [read post]
3 Apr 2018, 7:12 am
Hui Zhang, Xiang Li, Dani Min and Jiao YuxinOn October 8, 2017, the Chinese Communist Party and the State Council jointly issued a special opinion on the reform of drug and medical device approval system (“Innovation Opinion”). [read post]
4 May 2017, 1:00 am
Jiao Yuxin, Hui Zhang and Yi WeiPharmaceutical polymorph patents are regarded as effective means and important secondary pharmaceutical patents to extend the life cycle of pharmaceutical patent protection. [read post]
9 Sep 2020, 12:26 pm
It also includes articles by New Leftist scholar Wang Hui analyzing international relations. [read post]
26 Jun 2013, 7:32 pm
The City University of Hong Kong's Centre for Comparative and Chinese Law hosted an International Conference on “The Rule of Law With Chinese Characteristics in Transition” held 5-7 June 2013 at the Connie Fan Multi-Media Conference Room, 4/F Chen Yick-Chi Building on the campus of CUHK. [read post]
4 Aug 2019, 1:26 pm
Thanks to the New York Times and Matt Richtel for “Tainted Pork, Ill Consumers and an Investigation Thwarted. [read post]
